Inferring cancer subnetwork markers using density-constrained biclustering

Bioinformatics

Volumn 26, Issue 18, 2010, Pages

  Dao, Phuong ^a   Colak, Recep ^a   Salari, Raheleh ^a   Moser, Flavia ^b   Davicioni, Elai ^c   Schönhuth, Alexander ^d   Ester, Martin ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c GenomeDx Biosciences Inc   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ALGORITHM; ARTICLE; BIOLOGY; BREAST TUMOR; CLASSIFICATION; COLON TUMOR; COMPUTER PROGRAM; EVALUATION; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; HUMAN; METHODOLOGY; NEOPLASM; QUALITY CONTROL; TUMOR SUPPRESSOR GENE;

ALGORITHMS; BENCHMARKING; BREAST NEOPLASMS; COLONIC NEOPLASMS; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENES, P53; HUMANS; NEOPLASMS; SOFTWARE; TUMOR MARKERS, BIOLOGICAL;

EID: 77956529131     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btq393     Document Type: Article

References (35)

1. Alizadeh,A. et al. (2000) Distinct types of diffuse large b-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
2. Barrett,T. et al. (2009) NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res., 37, D885-D890.
3. Beer,D. et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8, 816-824.
4. Beroukhim,R. et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature, 463, 899-905.
5. Burger,M. (2008) Mcm2 and mcm5 as prognostic markers in colon cancer: a worthwhile approach. Dig. Dis. Sci., 54, 197-198.
6. Campbell,P. et al. (2008) Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat. Genet., 40, 722-729.
7. Chowdhury,S. and Koyutürk,M. (2010) Identification of coordinately dysregulated subnetworks in complex phenotypes. Pac. Symp. Biocomput., 15, 133-144.
8. Chuang,H.-Y. et al. (2007) Network-based classification of breast cancer metastasis. Mol. Syst. Biol., 3, 140.
9. Colak,R. (2008) Towards finding the complete modulome: density constrained biclustering. Master's thesis, School of Computing Science, Simon Fraser University, Burnaby, BC, Canada.
10. Colak,R. et al. (2009) Dense graphlet statistics of protein interaction and random networks. Pac. Symp. Biocomput., 14, 178-189.
11. Colak,R. et al. (2010) Module discovery by exhaustive search for densely connected, co-expressed regions in biomolecular interaction networks. PLoS One in press.
12. Dittrich,M. et al. (2008) Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics, 24, i223-i231.
13. Ein-Dor,L. et al. (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics, 21, 171-178.
14. Ein-Dor,L. et al. (2006) Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc. Natl Acad. Sci. USA, 103, 5923-5928.
15. Fearon,E. and Vogelstein,B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
16. Gasco,M. et al. (2002) The p53 pathway in breast cancer. Breast Cancer Res., 4, 70-76.
17. Georgii,E. et al. (2009) Enumeration of condition-dependent dense modules in protein interaction networks. Bioinformatics, 25, 933-940.
18. Golub,T. et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286, 531-537.
19. Hampton,O. et al. (2009) A sequence-level map of chromosomal break points in the mcf-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res., 19, 167-177.
20. Ideker,T. et al. (2002) Discovering regulatory and signaling circuits in molecular interaction networks. Bioinformatics, 18, 233-240.
21. Jensen,L. et al. (2009) String 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res., 37, D412-D416.
22. Jiang,X. et al. (2008) Dact3 is an epigenetic regulator of wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell, 13, 529-541.
23. Ki,D. et al. (2007) Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int. J. Cancer, 121, 2005-2012.
24. Macdonald,F. et al. (2004) Colorectal cancer. In Molecular Biology of Cancer. Routledge, Taylor & Francis Group, London.
25. Miller,L. et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl Acad. Sci. USA, 102, 13550-13555.
26. Moser,F. et al. (2009) Mining cohesive patterns from graphs with feature vectors. In SIAM International Conference on Data Mining (SDM). Sparks, Nevada, USA.
27. Nibbe,R. et al. (2010) An integrative-omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput. Biol., 6, e1000639.
28. Rosenwald,A. et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large b-cell lymphoma. N. Engl. J. Med., 346, 1937-1947.
29. Sabates-Bellver,J. et al. (2007) Transcriptome profile of human colorectal adenomas. Mol. Cancer Res., 5, 1263-1275.
30. Schölkopf,B. and Smola,A. (2002) Learning with Kernels. MIT Press, Cambridge, MA.
31. Sharan,R. et al. (2007) Network-based prediction of protein function. Mol. Syst. Biol., 3, 88.
32. Ulitsky,I. et al. (2008) Detecting disease-specific dysregulated pathways via analysis of clinical expression profiles. In Research in Computational Biology (RECOMB), Vol. 4955 of LNBI. Springer, Singapore, pp. 347-359.
33. van de Vijver,M. et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med., 347, 1999-2009.
34. Wang,Y. et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet, 365, 671-679.
35. Xu,M. et al. (2007) An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. BMC Genomics, 9 (Suppl. 1), S12.